with your 30b valuation ceiling for early 2022 buyout, you valued post 1 at preclinical and 2.5b. given it has the most potential(as per Dr T.) are we not doing it justice?
although I agree with you that we will probably not get a buyout figure that would potential be equal to the success of 3 pillars, would that mean the ultimate deal would be buyout with royalties? Would this type of deal get the most out of pillar 2/3?
The RAC 3-Pillar Trifecta, page-408
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 1305 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |